Proteins and Peptides

25 Jun 2007 BYETTA(R) Study Showed Comparable Blood Glucose Control to Insulin
24 Jun 2007 SYMLIN(R) Used in Conjunction with Basal Insulin in Patients with Type 2 Diabetes
24 Jun 2007 BYETTA(R) Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
22 Jun 2007 Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
22 Jun 2007 Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
21 Jun 2007 Shire in-licenses JUVISTA(R) (human TGFβ3) from Renovo
21 Jun 2007 Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
21 Jun 2007 King Pharmaceuticals Announces FDA Approval of Epistaxis Kit for THROMBIN-JMI(R)
20 Jun 2007 ZymoGenetics Establishes Global Collaboration With Bayer HealthCare for Development and Commercialization of Recombinant Human Thrombin
20 Jun 2007 Merck Serono and Ambrx to collaborate on development of next generation growth hormone products
20 Jun 2007 Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
20 Jun 2007 ConjuChem Biotechnologies Reports PC-DAC(TM):Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
19 Jun 2007 Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
19 Jun 2007 Presentation of In Vivo HDL Kinetic Data at the European Atherosclerosis Society 76th Congress Demonstrates Activation of Reverse Cholesterol Transport by Pre-Beta HDL in Selectively Delipidated
16 Jun 2007 Novo Nordisk and Neose announce initiation of phase 1 clinical trial of long-acting factor VIIa
15 Jun 2007 Fabry Study Demonstrates Sustained, Long-Term Renal Stabilization After 54 Months
13 Jun 2007 IBPL Becomes Country's First Dedicated Biopharmaceutical Facility to Receive EU-GMP Certification
13 Jun 2007 Eurand Files NDA for Zentase(TM) for Exocrine Pancreatic Insufficiency
12 Jun 2007 Phase III clinical trial with 4-month long-acting formulation of triptorelin: Ipsen decides not to perform further administration
12 Jun 2007 Altus Pharmaceuticals Reacquires European Development and Commercialization Rights to ALTU-135
09 Jun 2007 Scios Announces Enrollment of First Patients in Ascend-HF
08 Jun 2007 Alkermes Announces Initiation of Phase I Clinical Study of AIR(R) Parathyroid Hormone
08 Jun 2007 Discovery Labs Initiates Phase 2 Clinical Trial in Children with Acute Respiratory Failure
08 Jun 2007 Human Genome sciences announces positive final results of Phase 2b trial of Albuferon(R)
08 Jun 2007 Lipid Sciences Announces Validation of Proprietary Peptide That Mimics Key Functions of Natural Human HDL

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top